In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Jaynie Siegel came up through Morgan Stanleys advisor training program and joined the team in 2018
No more distracting thoughts about food when trying to be productive
Estrella JS, Hofstetter WL, Correa AM, Swisher SG , Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM
What labs should women with PMOS ask about before considering GLP-1s